The US FDA has granted the generics company Teva approval to launch a generic version of amoxicillin/clavulanic acid

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.389, 2002-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The US FDA has granted tentative approval to Teva Pharmaceutical's Abbreviated New Drug Application (ANDA) for lansoprazole.

By  

Inpharma, Vol. 1, Iss. 1623, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Teva receives first US approval for generic budesonide respules.

By  

Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Amoxicillin/clavulanic acid: Erythema multiforme: case report

By  

Reactions Weekly, Vol. 1, Iss. 1239, 2009-01 ,pp. : 4-5

Adis International

Access to resources Recommend Favorite

ADR-related costs higher with amoxicillin/clavulanic acid

By  

Reactions Weekly, Vol. 1, Iss. 1086, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Amoxicillin/clavulanic acid: Cholestatic hepatitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1210, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite